Lack of evidence of seronegative infection in an endemic area of Chagas disease

AUTOR(ES)

Oliveira, Léa Campos de

FONTE

Rev. Inst. Med. trop. S. Paulo

DATA DE PUBLICAÇÃO

14/02/2019

RESUMO

ABSTRACT The diagnosis of Chagas disease is based on the detection of Trypanosoma cruzi (T. cruzi)-specific antibodies. Nonetheless, there is concern about the sensitivity of current serological assays due to reports of T. cruzi PCR positivity among seronegative individuals. The aim of this study was to evaluate if T. cruzi seronegative infections occur in endemic areas. We recruited 2,157 individuals that were identified as having Chagas disease in a public health system database of an endemic region in Brazil. All participants were interviewed and 2,091 had a sample collected for serological and PCR testing. From these, 149 (7.1%) had negative serological results. PCR was positive in 610 samples (31.4%) of the 1,942 seropositive samples but in none of the 149 samples from seronegative participants. True T. cruzi seronegative infections seem to be rare (95% CI 0-3.7) and should not be a concern for blood supply, which relies on antibody screening.

Documentos Relacionados

• Chagas disease: morbidity profile in an endemic area of Northeastern Brazil
• Analysis of the seroprevalence of and factors associated with Chagas disease in an endemic area in Northeastern Brazil
• Predominance of Trypanosoma rangeli infection in children from a Chagas disease endemic area in the west-shore of the Panama canal
• Absence of domestic triatomine colonies in an area of the coastal region of Ecuador where Chagas disease is endemic
• Access to diagnosis and treatment of Chagas disease/infection in endemic and non-endemic countries in the XXI century